文献速递肝病消化道肿瘤与早癌

酒精相关性肝病背景下的肝细胞癌

Hepatocellular carcinoma in the setting of alcohol-related liver disease.
PubMed 文献 · J Hepatol · 2019-01-01

酒精相关性肝病是全球最常见的慢性肝病,占肝细胞癌(HCC)病例和HCC特异性死亡的30%。酒精致癌风险从低至10g/1单位/天的剂量开始,机制涉及乙醛毒性、活性氧增加、脂质过氧化、炎症、免疫受损和DNA甲基化改变。欧洲大型队列显示酒精性肝硬化患者HCC年发病率高达2.9%,受年龄、性别、肝衰竭和遗传多态性等宿主因素调节。由于监测受损和依从性差,HCC常晚期发现,预后较非酒精性HCC差。

要点

  • 酒精相关性肝病占全球HCC病例和HCC特异性死亡的30%。
  • 酒精致癌风险从低至10g/1单位/天的剂量开始。
  • 欧洲大型队列中酒精性肝硬化患者HCC年发病率高达2.9%。

核心结论

  • 酒精相关性肝病是全球最常见的慢性肝病,占HCC病例和HCC特异性死亡的30%。
  • 酒精相关性HCC患者常因监测受损和依从性差而晚期发现,预后较非酒精性HCC差。

研究设计与样本

  • 综述,检索范围未在摘要中报告。

主要发现

  • 酒精相关性肝病占HCC病例和HCC特异性死亡的30%。
  • 酒精致癌风险从低至10g/1单位/天的剂量开始。
  • 致癌过程包括乙醛直接毒性形成蛋白和DNA加合物、活性氧产生增加、脂质过氧化和代谢改变、炎症和免疫应答受损以及DNA甲基化修饰。
  • 欧洲大型队列中酒精性肝硬化患者HCC年发病率高达2.9%,受年龄、性别、肝衰竭和影响致癌通路的遗传多态性等宿主因素调节。
  • 由于监测受损和患者依从性差,酒精病因慢性肝病患者HCC常晚期发现,且多在晚期肝硬化背景下而非监测程序中发现,导致HCC更晚期、更不适合治愈性治疗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Alcohol-related liver disease is the most prevalent type of chronic liver disease worldwide, accounting for 30% of hepatocellular carcinoma (HCC) cases and HCC-specific deaths. Alcohol has been associated with an increased risk of several malignancies, this risk starting at doses as low as 10 g/1 unit/day. The carcinogenic process includes direct acetaldehyde toxicity through the formation of protein and DNA adducts, an increased production of reactive oxygen species, changes to lipid peroxidation and metabolism, inflammation and an impaired immune response and modifications to DNA methylation. A high annual incidence of HCC has been observed in large European cohorts of patients with alcoholic cirrhosis, reaching 2.9%, with numerous host factors modulating this risk (age, gender, liver failure, genetic polymorphisms affecting oncogenic pathways). Because of impaired surveillance and poor patient compliance, HCC is often detected late in patients with chronic liver disease of alcoholic aetiology. This delay in detection, which is frequently made in the context of advanced liver cirrhosis rather than in surveillance programmes, results in more advanced HCC that is less amenable to curative treatment. Consequently, patients with alcohol-related HCC generally have a worse prognosis than those with non-alcoholic HCC.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Ganne-Carrié N, Nahon P. Hepatocellular carcinoma in the setting of alcohol-related liver disease. J Hepatol. 2019. PMID: 30658729. doi:10.1016/j.jhep.2018.10.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。